Tursi James Patrick
Insider CIK 1527710 · ATRS EVP, Chief Medical Officer · POZN Chief Medical Officer · AUXL Chief Medical Officer · AGRX Director · ENDP Executive VP, Global R&D · NRBO Director · ARLZ Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MTVA MetaVia Inc. | A Award | 2026-06-08 | 2026-06-08 | 17,186 | — | $0 | 20,568 | SEC↗ |
| MTVA MetaVia Inc. | A Award | 2025-06-30 | 2025-07-01 | 28,147 | — | $0 | 37,219 | SEC↗ |
| NRBO NeuroBo Pharmaceuticals, I | A Award | 2024-06-07 | 2024-06-07 | 5,051 | — | $0 | 9,072 | SEC↗ |
| NRBO NeuroBo Pharmaceuticals, I | A Award | 2023-12-01 | 2023-12-04 | 7,157 | — | $0 | 32,157 | SEC↗ |
| NRBO NeuroBo Pharmaceuticals, I | A Award | 2023-12-01 | 2023-12-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ENDP Endo International plc | D To issuer | 2022-07-15 | 2022-08-17 | 280,373 | — | $0 | 0 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2022-06-09 | 2022-06-10 | 807 | — | $0 | 807 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award | 2022-06-09 | 2022-06-10 | 670 | — | $0 | 2,066 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2021-06-08 | 2021-06-10 | 29,905 | — | $0 | 29,905 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award | 2021-06-08 | 2021-06-10 | 24,510 | — | $0 | 55,852 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2020-06-09 | 2020-06-11 | 22,606 | — | $0 | 22,606 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award | 2020-06-09 | 2020-06-11 | 13,393 | — | $0 | 31,342 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2019-06-13 | 2019-06-14 | 90,788 | — | $0 | 90,788 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2019-06-13 | 2019-06-14 | 45,205 | $2.92 | $132.0K | 45,205 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2019-06-06 | 2019-06-07 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2018-08-06 | 2018-08-07 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | M Exercise deriv | 2018-06-08 | 2018-06-08 | 17,949 | — | $0 | 0 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | M Exercise | 2018-06-08 | 2018-06-08 | 17,949 | — | $0 | 17,949 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2018-06-07 | 2018-06-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | S Sale | 2018-05-14 | 2018-05-16 | 9,348 | $0.52 | $4.9K | 242,052 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | S Sale | 2018-03-19 | 2018-03-21 | 5,950 | $1.70 | $10.1K | 251,400 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | S Sale | 2017-10-02 | 2017-10-04 | 9,960 | $2.50 | $24.9K | 257,350 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2017-06-08 | 2017-06-09 | 17,949 | — | $0 | 17,949 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2017-06-08 | 2017-06-09 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award deriv | 2017-05-11 | 2017-05-12 | 96,121 | — | $0 | 96,121 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award | 2017-05-11 | 2017-05-12 | 83,192 | — | $0 | 267,310 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | P Buy | 2017-03-15 | 2017-03-17 | 4,750 | $2.11 | $10.0K | 184,118 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2016-06-08 | 2016-06-09 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | P Buy | 2016-05-20 | 2016-05-23 | 10,000 | $3.75 | $37.5K | 179,368 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | P Buy | 2016-05-16 | 2016-05-18 | 4,500 | $3.79 | $17.1K | 169,368 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award deriv | 2016-03-17 | 2016-03-18 | 40,096 | — | $0 | 40,096 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award | 2016-03-17 | 2016-03-18 | 47,368 | — | $0 | 164,868 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award | 2016-02-12 | 2016-02-17 | 86,863 | — | $0 | 117,500 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | J Other | 2016-02-05 | 2016-02-09 | 30,637 | — | $0 | 30,637 | SEC↗ |
| POZN POZEN INC /NC | A Award | 2015-10-01 | 2015-12-30 | 29,137 | — | $0 | 30,637 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2015-06-10 | 2015-06-10 | 14,000 | — | $0 | 14,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 35,000 | $36.53 | $1.28M | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 24,750 | $36.53 | $904.1K | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 13,000 | $36.53 | $474.9K | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 25,000 | $36.53 | $913.3K | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 28,500 | $36.53 | $1.04M | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 2,438 | $36.53 | $89.1K | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 12,500 | $36.53 | $456.6K | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other | 2015-01-29 | 2015-01-30 | 3,398 | — | $0 | 29,236 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other | 2015-01-29 | 2015-01-30 | 29,236 | $36.53 | $1.07M | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise deriv | 2014-11-25 | 2014-11-26 | 2,312 | — | $0 | 2,438 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise deriv | 2014-11-25 | 2014-11-26 | 8,250 | — | $0 | 24,750 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | S Sale | 2014-11-25 | 2014-11-26 | 3,151 | $34.13 | $107.5K | 31,904 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise | 2014-11-25 | 2014-11-26 | 2,312 | $22.04 | $51.0K | 37,367 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise | 2014-11-25 | 2014-11-26 | 8,250 | $18.30 | $151.0K | 45,617 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | S Sale | 2014-11-25 | 2014-11-26 | 10,562 | $34.12 | $360.4K | 35,055 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise deriv | 2014-11-21 | 2014-11-24 | 5,000 | — | $0 | 4,750 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise | 2014-11-21 | 2014-11-24 | 5,000 | $22.04 | $110.2K | 109,703 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | S Sale | 2014-11-21 | 2014-11-24 | 3,648 | $33.45 | $122.0K | 40,055 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | S Sale | 2014-11-21 | 2014-11-24 | 5,000 | $33.49 | $167.4K | 35,055 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise deriv | 2014-11-20 | 2014-11-24 | 37,500 | — | $0 | 12,500 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise deriv | 2014-11-20 | 2014-11-24 | 28,500 | — | $0 | 28,500 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise | 2014-11-20 | 2014-11-24 | 28,500 | $19.51 | $556.0K | 104,703 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise | 2014-11-20 | 2014-11-24 | 37,500 | $14.10 | $528.8K | 76,203 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | S Sale | 2014-11-20 | 2014-11-24 | 6,200 | $32.94 | $204.2K | 103,503 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | S Sale | 2014-11-20 | 2014-11-24 | 59,800 | $33.18 | $1.98M | 43,703 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2014-10-01 | 2014-10-02 | 21,000 | — | $0 | 21,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2014-02-18 | 2014-02-20 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2014-02-18 | 2014-02-20 | 35,000 | — | $0 | 35,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-02-20 | 6,375 | — | $0 | 24,409 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2014-02-18 | 2014-02-20 | 704 | $28.30 | $19.9K | 23,705 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-02-20 | 14,500 | — | $0 | 38,205 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-02-28 | 6,375 | — | $0 | 24,409 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-03-12 | 14,500 | — | $0 | 38,205 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2014-02-17 | 2014-02-19 | 108 | $26.80 | $2.9K | 18,034 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2014-02-07 | 2014-02-11 | 2,043 | $23.68 | $48.4K | 18,142 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-07 | 2014-03-12 | 13,200 | — | $0 | 19,434 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2013-02-07 | 2013-02-11 | 33,000 | — | $0 | 33,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2013-02-07 | 2013-02-11 | 426 | $18.30 | $7.8K | 19,008 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-07 | 2013-02-11 | 3,940 | — | $0 | 6,234 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-07 | 2013-02-11 | 13,200 | — | $0 | 19,434 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2012-02-14 | 2012-02-16 | 57,000 | — | $0 | 57,000 | SEC↗ |